Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Hypocalcemia 1Hyperparathyroidism, Secondary 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Zoledronic Acid 2Vincristine 2Irinotecan 2Gemcitabine 2Etoposide 2Doxorubicin 2Cyclophosphamide 2saracatinib 1robatumumab 1radium Ra 223 dichloride 1liposomal doxorubicin 1cc-486 1Temozolomide 1Taxes 1Standard of Care 1Radiation 1Quality of Life 1Psychology, Positive 1Practice Guidelines as Topic 1Patient Reported Outcome Measures 1Palliative Care 1Paclitaxel 1Observation 1Molecular Diagnostic Techniques 1Methods 1Lomustine 1Injections 1Immunotherapy 1Ifosfamide 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × Calcifediol × Genitourinary × Clear all
NCT02274623 2019-09-27

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

OPKO Health, Inc.

Phase 1 Completed
33 enrolled
BreastGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Breast Neoplasms, Hyperparathyroidism, Secondary, Hypocalcemia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡